Table 1.
Primary inputs harmonized across models.
| Input | Value | Sources | 
|---|---|---|
| Target population by country | Approximately 90 million pregnant women globally, per year | United Nations Population Database, 2017 and Lawn et al., 2016 [11], [12] | 
| Vaccine schedule | Single dose provided year-round as part of ANC services | Preferred Product Characteristics [13]; expert opinion | 
| Vaccination window | 24–36 weeks of gestation | Preferred Product Characteristics [13]; expert opinion | 
| Vaccine coverage by country | Average in year 2023, 69% (21%–96%) | DHS and WHO [14], [15] | 
| Vaccine introduction dates by country | Phased, 2023 to 2035 | Product development timeline [8]; prior vaccine introduction | 
| Vaccine efficacy for infant protection | Midpoint 60% | Preferred Product Characteristics [13]; expert opinion | 
| Duration of protection | Midpoint 5 months, no waning before 5 months | Preferred Product Characteristics [13]; expert opinion | 
Abbreviations: ANC, antenatal care; DHS, Demographic and Health Surveys; WHO, World Health Organization.